Key Drivers
- Strong cash position
- Persistent losses
- Trades below book
AIAI Summary
Kodak should be reclassified from a distressed-imaging turnaround to a cash-rich, niche contract manufacturer where the key upside is executing a regulated-pharma pivot that could convert the one‑time pension/FCF windfall into durable, higher-margin recurring revenue. The single biggest risk is management's capital-allocation and execution on GMP qualification/customer wins—proof will be consistent quarters of adjusted positive EBITDA and visible, non‑one‑off FCF conversion rather than headline-driven volatility.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong cash position
- •Persistent losses
- •Trades below book
Kodak has a strong balance sheet and exceptional FY2025 free cash flow but persistent operating losses, negative ROA/ROE and volatile quarterly results despite trading below tangible book.
Price Behavior
Key Price Behavior Insights:
- •Mild uptrend
- •Higher lows
- •Near-term resistance
KODK shows a mild short-term uptrend over the last month, gaining roughly 2–3% from about $7.63 to $7.83 while holding support near $6.69 but facing resistance around $7.90–$8.00.
Steady recovery off $6.69 low rather than a sharp rally
Sentiment & News
Key News Insights:
- •Revenue growth
- •Higher cash
- •Pension charge
Kodak showed stronger revenue, margins and cash but a one-time pension charge converted GAAP results into a loss, driving volatile post-earnings trading. #pension-charge
Underlying operational improvement supports upside potential, but the nonrecurring pension hit clouds near-term GAAP outlook and may keep shares volatile
Similar Companies in Industrials
Other companies in the same sector with AI ratings